Your browser doesn't support javascript.
loading
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.
Lanjouw, Lieke; Mourits, Marian J E; Bart, Joost; Ter Elst, Arja; Berger, Lieke P V; van der Hout, Annemieke H; Alam, Naufil; de Bock, Geertruida H.
  • Lanjouw L; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands l.lanjouw@umcg.nl.
  • Mourits MJE; Department of Obstetrics and Gynecology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Bart J; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Ter Elst A; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Berger LPV; Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • van der Hout AH; Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Alam N; AstraZeneca Pharmaceuticals LP, Cambridge, UK.
  • de Bock GH; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Int J Gynecol Cancer ; 33(8): 1260-1269, 2023 08 07.
Article en En | MEDLINE | ID: mdl-37137525

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína BRCA1 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Aged / Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína BRCA1 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Aged / Female / Humans Idioma: En Año: 2023 Tipo del documento: Article